# BREXOGEN

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/brexogen

- Industry: Pharmaceuticals
- Headquarters: Seoul, South Korea
- Website: www.brexogen.com
- Total disclosed funding: $24M
- Latest round: Series C (Sep 1, 2023)
- Investors on record: 10

## About

Founded in 2019 and based in Seoul, South Korea, BREXOGEN operates as a pharmaceutical company that researches and develops new exosome-based medicine. In September 2023, BREXOGEN raised KRW 12 billion in series C funding from new investor Kolmar Holdings, with participation from returning investors UTC Investment, Time Folio Asset Management, Korea Investment Partners, and KDB Bank. As of 2023, the company is led by its CEO Kim Soo.

The company will use the September funding to complete the phase 1 clinical trial of the first pipeline, atopic dermatitis exosome treatment (BRE-AD01), currently underway in the United States for patients with severe atopic dermatitis, and to develop the second pipeline, myocardial infarction exosome treatment (BRE-AD01). It will be used for non-clinical research and production costs of clinical trial drugs for entry into phase 1 clinical trials of MI01).

## Funding rounds

- Series C, Sep 1, 2023, $9.1M — KDB Bank, Korea Investment Partners, UTC Investment, Time Folio Asset Management, Kolmar Holdings
- Series B, Jan 21, 2022, $8.3M — KDB Bank, Korea Investment Partners, Timefolio Asset Management, UTC Investment, KB Securities, Korea Venture Investment Corporation
- Series A, Sep 21, 2020, $6.5M — Korea Investment Partners, UTC Investment, KB Securities, Time Folio Asset Management, Log Investment, Stonebridge Ventures

## Investors

- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A, Series B, Series C
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series A, Series B, Series C
- KB Securities (https://capitalatlas.ai/funds/kb-securities) — Series A, Series B
- Time Folio Asset Management — Series A, Series C
- Log Investment (https://capitalatlas.ai/funds/log-investment) — Series A
- Stonebridge Ventures — Series A
- KDB Bank — Series B, Series C
- Timefolio Asset Management — Series B
- Korea Venture Investment Corporation (https://capitalatlas.ai/funds/korea-venture-investment-corporation) — Series B
- Kolmar Holdings — Series C